NARI

NARI

NARI

Letters With This Ticker

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Keywords/Themes	Theme Commentary	Pitches	Letter
2024 Q1	Apr 15, 2024	Baron Discovery Fund	13.5%	9.3%	AEIS, ALGM, AXNX, AXON, CDNA, CYBR, DKNG, ENDV, ESTA, FND, GTLB, INTA, KNSL, MASI, MRCY, NARI, NVTS, RH, S, SITE	cybersecurity, growth, healthcare, semiconductors, small cap, technology, Valuations	Fund focuses on small-cap growth stocks which remain in a three-plus year bear market while large-cap stocks reach all-time highs. Small-cap growth stocks have attractive valuations both on an absolute basis and relative to large-cap stocks, and typically show significant appreciation coming out of deep market downturns.	INTA MASI CYBR DKNG KNSL	View
2025 Q1	Mar 31, 2025	Baron Discovery Fund	-6.2%	-6.2%	AXON, CWAN, CYBR, DKNG, EXAS, GTLS, GWRE, INDI, INSP, KTOS, LLYVA, MASI, MEG, MRCY, NARI, PAR, RDDT, TEM, TTAN, WING	Biotechnology, defense, growth, Market Dislocation, small cap, tariffs, Value Investing	The fund has significant exposure to defense companies including Kratos Defense & Security Solutions and newly added Karman Holdings. These companies are positioned to benefit from growing defense spending on hypersonic missiles, space programs, and unmanned aircraft solutions. Karman specifically targets the fastest-growing segments of defense with 90% sole-sourced sales and proprietary IP-driven solutions.	ACLX KARM WING MEG INDI EXAS	View
2025 Q1	Mar 31, 2025	Baron Opportunity Fund	-12.0%	-12.0%	AAPL, AMZN, ARGX, AVGO, CSGP, CYBR, LPLA, META, MPWR, MSFT, NARI, NVDA, NVMI, SNOW, SPOT, TEAM, TSLA, TTD, VRT, ZS	AI, growth, innovation, large cap, semiconductors, tariffs, technology, Trade Policy	AI remains the most powerful technology platform shift and secular growth driver since the internet. Despite tariff uncertainty affecting valuations of AI leaders like NVIDIA and Broadcom, robust AI capital investment plans continue through 2025-2026. The manager believes AI will drive productivity-driven digital transformation, with tech spending potentially doubling from 5% to 10% of global GDP.		View
2025 Q1	Mar 31, 2025	Voya MidCap Opportunities Strategy	-	-	ALAB, NARI, PSN, TTD, TW, WELL	AI, Capital markets, defense, growth, healthcare, mid cap, real estate, technology	The artificial intelligence sector experienced significant challenges during the quarter, with emerging cracks in the AI sector contributing to market uncertainty. Chinese AI rival Deepseek's announcement negatively impacted AI-related stocks like Astera Labs. Big technology stocks, including AI-focused companies, fell into bear-market territory.		View
2024 Q4	Dec 31, 2024	Baron Opportunity Fund	11.9%	39.9%	AAPL, AMD, AMZN, ANET, ARGX, ASML, AVGO, CRWD, CYBR, GOOGL, INDI, LPLA, META, MPWR, MSFT, NARI, NVDA, PCVX, RCKT, SHOP, SPOT, TEAM, TSLA, TTD, VKTX, ZS	AI, growth, innovation, large cap, secular trends, technology	AI infrastructure demand continues to drive robust performance across compute, networking, and systems. NVIDIA maintains unmatched leadership spanning GPUs, systems, software and networking solutions. The advent of reasoning models requiring multiple passes through models is expected to significantly increase compute intensity in both training and inference.	CYBR LPLA ANET NVDA TSLA	View
2024 Q3	Sep 30, 2024	Baron Discovery Fund	13.5%	9.3%	AEIS, AXON, BASE, CDNA, CWAN, CYBR, DKNG, EXAS, GTLS, GWRE, INDI, KTOS, LLYVA, MEG, NARI, PTECH, SIZE, TEM, TWFG, VCYT	growth, healthcare, rates, Rotation, small caps, technology, valuation	The fund believes the bear market in small-cap growth stocks that started in February 2021 is finally ending. Small-cap growth is trading at its largest discount relative to large cap in 25 years, with investors under-allocated to the asset class. The combination of lower interest rates, stronger economic growth, attractive valuations, and easier earnings comparisons creates a backdrop conducive for stronger small company fundamentals and valuation multiples.	NARI TWFG TEM AXON CDNA	View
2025 Q1	Mar 31, 2025	Alger Small Cap Focus Fund	-21.8%	-21.8%	AGYS, FTAI, GWRE, NARI, SYK, WGS, XMTR	AI, Cloud, Genomics, healthcare, Medical Devices, small caps, technology, volatility	The emergence of advanced AI models from China demonstrated capabilities comparable to leading U.S. models but at significantly lower development costs. This prompted investors to reassess the substantial capital expenditures of U.S. large-cap technology companies, resulting in a sell-off in AI-related stocks and concerns over the potential returns on domestic AI initiatives. AI is at an inflection point, potentially enabling significant increases in productivity.	FTAI XMTR AGYS GWRE GDXH NARI	View
2023 Q4	Jan 13, 2024	ClearBridge Investments Small Cap Growth Strategy	0.0%	0.0%	BLKB, CHX, EYE, FOUR, FOXF, IBP, LSCC, MIRM, MPWR, NARI, NVDA, SILK, SMCI, STAA, TREX, VRNS, WHD, WING, WMT	AI, Biotech, growth, healthcare, industrials, M&A, small cap, technology	Generative artificial intelligence captured significant attention with OpenAI's ChatGPT driving massive investment in rival models and infrastructure build in data centers and GPU-heavy AI servers. Public market capital chased AI beneficiaries while selling perceived disrupted businesses, with most significant winners in large cap universe.	IBP MIRM BLKB NARI	View

Pitches With This Ticker

Date	Pitch Type	Author	Company	Industry	Sub Industry	Bull / Bear	Stock Exchange	Keywords	Action
Apr 28, 2026	Fund Letters	ClearBridge Investments Small Cap Growth Strategy	Inari Medical	Health Care Equipment & Services	Health Care Equipment	Bull	NASDAQ	Blood Clots, growth, healthcare innovation, market penetration, Medical Device, Vascular Intervention, Venous Thromboembolism	View Pitch
Apr 13, 2026	Fund Letters	Alger Small Cap Focus Fund	Inari Medical, Inc.	Health Care Equipment & Services	Health Care Equipment	Bull	NASDAQ	acquisition target, Clot Removal, Healthcare Technology, M&A, Medical devices, Minimally Invasive, Venous Disease Treatment	View Pitch
Apr 13, 2026	Fund Letters	Baron Discovery Fund	Inari Medical, Inc.	Health Care	Health Care Equipment & Supplies	Bull	NASDAQ	Clinical Studies, DVT, Equity, International, Market expansion, Medical devices, PE, Thromboembolism, Vascular	View Pitch

BSD Shareholders of NARI

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025

Manager Name	Fund Name	Fund AUM	Invested Value	Portfolio Weight	Shares Owned	Shares Bought / Sold During Quarter	% Bought / Sold During Quarter	% of Shares Outstanding Owned
No investor data available.

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

Follow Us On: